Fulvestrant as EFECTive as exemestane in advanced breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1570, 2007-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer

By Robertson J.F.R.

Clinical Pharmacokinetics, Vol. 43, Iss. 8, 2004-01 ,pp. : 529-538

Adis International

Access to resources Recommend Favorite

Fulvestrant: benefits at acceptable costs in advanced breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 571, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

By Lønning Per Eystein Geisler Jürgen

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Exemestane and aromatase inhibitors in the management of advanced breast cancer

By Dixon J Michael

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 307-316

Informa Healthcare

Access to resources Recommend Favorite

Fulvestrant – a new treatment for postmenopausal women with hormone-sensitive advanced breast cancer

By Possinger Kurt

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2549-2558

Informa Healthcare

Access to resources Recommend Favorite